About ​David Bostwick

Recognized for his exceptional career in pathology, diagnostics, and healthcare management, Dr. David G. Bostwick, M.D., M.B.A., F.C.A.P., excels as a distinguished medical professional and entrepreneur. With substantial experience in clinical practice and corporate leadership, he has significantly influenced advancements in medicine and the healthcare sector.

​In 2018, Dr. Bostwick founded Rampart Health in Orlando, FL. Under his leadership, the company completed FDA-cleared phase II clinical trials in 2023 for a first-in-human multiplex combination immunotherapy for metastatic and all solid cancers.

Dr. Bostwick is the CEO of Triopsy Inc., the Chief Medical Officer and Laboratory Director at Granger Genetics, and the CEO and General Manager at Rampart Health.

To learn more about David Bostwick, visit DavidBostwick.com.